Skip to content

Overview of Telemedicine in Children With Type 1 Diabetes

State of Play of Telemedicine in the Follow-up of Children With Type 1 Diabetes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05348551
Acronym
TLS-DID
Enrollment
4800
Registered
2022-04-27
Start date
2022-05-20
Completion date
2022-07-20
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Only, Diabetes Mellitus, Type 1, Telemedicine

Keywords

Diabetes mellitus type 1, Children, Telemedicine

Brief summary

Assessment of the proportion of pediatric patients with type 1 diabetes with access to remote monitoring

Detailed description

In the follow-up of type 1 diabetes in children, contact with families besides the appointements with medical et paramedic staff (paediatrician, diabetologist, nurses) is very common but not well coded, start from telehealth hubs (like myDiabby), to less unofficial contact by phone or email. This is even more so widespread since generalization of continuous glucometer (freestyle, dexcom,...), which allowed a quick data transfer to the medical staff. Some studies had shown that telemedicine in diabetes allowed a better glycemic control and a higher implication in the desease. Indeed, in 1999 already, HbA1c significant improvement was shown when patients was regularly called by a nurse (Thompson et al.). Same finding was demonstrated in Schiaffini and al. clinical trial in 2016. This trial also shown a better adhesion to the follow up into the telemedicine group. Despite all of this studies, in France, remote monitoring isn't standardised and financed, except the national experimentation ETAPES which promotes and financially supports the deployment of remote monitoring projects around the territory.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children with type 1 diabetes

Exclusion criteria

* No consent

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the proportion of pediatric patients with access to remote monitoring1 dayProportion of pediatric patients with access to remote monitoring

Secondary

MeasureTime frameDescription
Description of the different means and modalities of remote monitoring for patients1 dayProportion of patients in the different modalities of remote monitoring
Evaluation of patients' (and parents') perception of telemonitoring using a scale1 dayPerceived importance of this remote monitoring score using a scale from 1 (mean no importance, I could do without) to 10 (mean it's very important, I think it's essential)

Contacts

Primary ContactClémentine DUPUIS
cdupuis2@chu-grenoble.fr0476760924

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026